{"id":"https://genegraph.clinicalgenome.org/r/ce4e0188-e7c0-4708-96b9-832f8f1854cdv1.0","type":"EvidenceStrengthAssertion","dc:description":"*AGXT* was first reported in relation to autosomal recessive alanine glyoxylate aminotransferase deficiency in 1991 (Nishiyama K et al., PMID: 2039493). At least 28 variants (e.g. missense, in-frame indel, nonsense, frameshift, etc) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. Summary of Case Level and Experimental Data: 16.5 points. Variants in this gene have been reported in at least 24 probands in 9 publications (PMIDs: 26383609, 8101040, 30341509, 27915025, 27659337, 2039493, 1349575, 18810341, 16931222).\nVariants in this gene segregated with disease in 3 additional family members. The gene-disease association is supported by animal models and expression studies. In summary, *AGXT* is definitively associated with autosomal recessive alanine glyoxylate aminotransferase deficiency. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/ce4e0188-e7c0-4708-96b9-832f8f1854cd","GCISnapshot":"https://genegraph.clinicalgenome.org/r/8460f17d-4d94-4a0c-ac46-41c86ce32e83","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/8460f17d-4d94-4a0c-ac46-41c86ce32e83_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10049","date":"2020-02-07T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/8460f17d-4d94-4a0c-ac46-41c86ce32e83_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10049","date":"2022-04-22T23:07:28.500Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8460f17d-4d94-4a0c-ac46-41c86ce32e83_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8460f17d-4d94-4a0c-ac46-41c86ce32e83_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c2711398-2f15-47b3-89cf-954b3cb347ab","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1552bfc6-cc66-4e89-9849-aa7e3a305e56","type":"Finding","dc:description":"null mice had normal development, when oxalate production was enhanced via ethylene glycol administration nephrocalcinosis and renal failure developed (Fig. 3), immunofluorescence studies of mice liver showed human AGXT was localized to mouse hepatocellurlar peroxisomes (Fig. 4)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17110443","rdfs:label":"Agxt -/- Mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d517dcea-9be2-48b8-9d56-40ca5de488bc","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d93d3604-625c-4f0a-a1a7-4abd17d52afa","type":"Finding","dc:description":"human AGXT was expressed in livers of null mice via adenoviral vector-mediated gene transfer which resulted in normalization of urinary oxalate excretion and oxalate crystalluria (Fig. 4)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17110443","rdfs:label":"Agxt -/- Mice Rescue","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/8460f17d-4d94-4a0c-ac46-41c86ce32e83_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6112901d-bb7a-4453-ae3b-dae9aff7c66c","type":"EvidenceLine","dc:description":"Primary expression in liver","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a26a116-753e-4fd1-ad6b-ca686174f994","type":"Finding","dc:description":"detected via RNA-Seq; https://www.ncbi.nlm.nih.gov/gene/6928","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24309898","rdfs:label":"NCBI Gene","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5},{"id":"https://genegraph.clinicalgenome.org/r/8460f17d-4d94-4a0c-ac46-41c86ce32e83_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bbcda31-0dc7-4520-9c34-e1e11ae9bfc3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/192df2fc-3179-483a-ab59-d7b4da0c51fe","type":"EvidenceLine","dc:description":"variant present on major allele and absent from gnomAD","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/192df2fc-3179-483a-ab59-d7b4da0c51fe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27915025","allele":{"id":"https://genegraph.clinicalgenome.org/r/1af7ab2b-ecca-4f81-86c9-a4063f33e615","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.458T>A (p.Leu153Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351315850"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2bbcda31-0dc7-4520-9c34-e1e11ae9bfc3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27915025","rdfs:label":"Patient 5-Family D","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1af7ab2b-ecca-4f81-86c9-a4063f33e615"},"detectionMethod":"Sequence analyses of AGXT gene were performed by using 25 ng PCR product, 3 pmol primer and BigDye Terminator","phenotypeFreeText":"bilateral nephrocalcinosis; treated with supportive therapy for kidney disease (peritoneal dialysis) and pyridoxine","phenotypes":["obo:HP_0000121","obo:HP_0002027","obo:HP_0000787","obo:HP_0003774","obo:HP_0003159"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/192df2fc-3179-483a-ab59-d7b4da0c51fe_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/bad735d4-5c37-4915-a16a-5727f59c1842_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd1a350b-d3e2-4f20-ae3a-373919f9bead","type":"EvidenceLine","dc:description":"Variant on major allele; absent in gnomAD; patient stated to be heterozygous, but no other variant is reported, scored as 0","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd1a350b-d3e2-4f20-ae3a-373919f9bead_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26383609","allele":{"id":"https://genegraph.clinicalgenome.org/r/3f5a70b7-7166-49b5-9d97-945c76527c6f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.331C>T (p.Arg111Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/204091"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/bad735d4-5c37-4915-a16a-5727f59c1842","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26383609","rdfs:label":"Patient 4","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/3f5a70b7-7166-49b5-9d97-945c76527c6f"},"detectionMethod":"genomic DNA isolated from peripheral blood, exons and flanking regions of AGXT PCR amplified, products directly sequenced","phenotypeFreeText":"PH diagnosed based on clinical findings, elevated plasma oxalate, and urinalysis in combination with spectrophotometric analysis of the calculation","phenotypes":"obo:HP_0003159","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cd1a350b-d3e2-4f20-ae3a-373919f9bead_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c7416949-2e2a-4aff-bfdd-1845af1bf63b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a276ff9d-6236-4bbd-809c-c028d371ab3e","type":"EvidenceLine","dc:description":"Scored as zero per expert reviewer's comments on 12/20/19. No variant evidence, variant present on minor allele and absent from gnomAD","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a276ff9d-6236-4bbd-809c-c028d371ab3e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27915025","allele":{"id":"https://genegraph.clinicalgenome.org/r/a4368525-7916-4c88-860b-7402c97c3f6f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.52C>T (p.Leu18Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351312842"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c7416949-2e2a-4aff-bfdd-1845af1bf63b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27915025","rdfs:label":"Patient 11-Family I","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":1,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a4368525-7916-4c88-860b-7402c97c3f6f"},"detectionMethod":"Sequence analyses of AGXT gene were performed by using 25 ng PCR product, 3 pmol primer and BigDye Terminator","phenotypeFreeText":"treated with supportive therapy for kidney disease (peritoneal dialysis) and pyridoxine, bilateral nephrolithiasis and nephrocalcinosis","phenotypes":["obo:HP_0003159","obo:HP_0003774","obo:HP_0000121","obo:HP_0000787","obo:HP_0001508"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/a276ff9d-6236-4bbd-809c-c028d371ab3e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/607c64d3-771b-40a0-b242-bd30f808308c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c968bf36-285a-4995-ba43-368d0bae9e05","type":"EvidenceLine","dc:description":"gnomAD frequency = 0.00004597, Variant present on minor allele in 22 other probands (2 compound heterozygotes, 20 homozygotes); Likely a founder mutation suggested by high frequency in Canary Islands in individuals of Spanish North African origin, thought to originate in island of La Gomera (PMID: 16912707)","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c968bf36-285a-4995-ba43-368d0bae9e05_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26383609","allele":{"id":"https://genegraph.clinicalgenome.org/r/984e0a29-9c06-4dbe-90c9-332a27dba5cd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.731T>C (p.Ile244Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/5646"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/607c64d3-771b-40a0-b242-bd30f808308c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26383609","rdfs:label":"Patient 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/984e0a29-9c06-4dbe-90c9-332a27dba5cd"},"detectionMethod":"genomic DNA isolated from peripheral blood, exons and flanking regions of AGXT PCR amplified, products directly sequenced","phenotypeFreeText":"PH diagnosed based on clinical findings, elevated plasma oxalate, and urinalysis in combination with spectrophotometric analysis of the calculation","phenotypes":"obo:HP_0003159","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c968bf36-285a-4995-ba43-368d0bae9e05_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/1c32b457-4671-4a09-b2c2-3eedf696ef07_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f7a63ac-6955-48f4-85bd-d1438852bc1e","type":"EvidenceLine","dc:description":"Scored as zero due to no evidence of variants being in trans. p.Arg360Gln: stated to be heterozygous, gnomAD = 0.000005914","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f7a63ac-6955-48f4-85bd-d1438852bc1e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot showed variant resulted in 16.7% expression of AGXT protein compared to WT (Fig. 2) and mass spec showed variant resulted in partial loss of protein activity (Fig. 3)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/0f7a63ac-6955-48f4-85bd-d1438852bc1e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","allele":{"id":"https://genegraph.clinicalgenome.org/r/8506797b-7006-46cc-87bb-4c2f0554b194","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.1079G>A (p.Arg360Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/204147"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/9db9c84b-84ce-40fb-81f8-b7c5a824294a","type":"EvidenceLine","dc:description":"Scored as zero due to no evidence of variants being in trans. p.Lys12fs: stated to be heterozygous, absent from gnomAD,","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9db9c84b-84ce-40fb-81f8-b7c5a824294a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot showed variant resulted in 100% loss of AGT protein expression (Fig. 2) and mass spec showed 100% loss of protein activity","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9db9c84b-84ce-40fb-81f8-b7c5a824294a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","allele":{"id":"https://genegraph.clinicalgenome.org/r/f34451f8-1c6e-4567-ad23-2feab877a79f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.33dup (p.Lys12GlnfsTer156)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/140583"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/1c32b457-4671-4a09-b2c2-3eedf696ef07","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","rdfs:label":"Patient V-3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":20,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/f34451f8-1c6e-4567-ad23-2feab877a79f"},{"id":"https://genegraph.clinicalgenome.org/r/8506797b-7006-46cc-87bb-4c2f0554b194"}],"detectionMethod":"exons, intron-exon boundaries and untranslated regions of AGXT screened via PCR and direct sequencing; both patients and family members underwent testing","phenotypes":"obo:HP_0000787","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/9db9c84b-84ce-40fb-81f8-b7c5a824294a_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/0f7a63ac-6955-48f4-85bd-d1438852bc1e_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/853de9e1-8b46-4497-948a-abb1e37f1b8d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51c6fdfd-4229-4a66-8efd-195dbf3eae86","type":"EvidenceLine","dc:description":"Scored as zero due to no evidence of variants being in trans p.Lys12fs: stated to be heterozygous, absent from gnomAD.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51c6fdfd-4229-4a66-8efd-195dbf3eae86_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot showed variant resulted in 100% loss of AGT protein expression","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/51c6fdfd-4229-4a66-8efd-195dbf3eae86_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","allele":{"id":"https://genegraph.clinicalgenome.org/r/f34451f8-1c6e-4567-ad23-2feab877a79f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/6cb8c15a-7140-4341-be04-7078fdbbcd3c","type":"EvidenceLine","dc:description":"Scored as zero due to no evidence of variants being in trans. p.Lys209Asn: stated to be heterozygous, absent from gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6cb8c15a-7140-4341-be04-7078fdbbcd3c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","allele":{"id":"https://genegraph.clinicalgenome.org/r/4f78b33a-6f72-4bb0-813a-6a7376086415","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.627G>C (p.Lys209Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351316873"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/853de9e1-8b46-4497-948a-abb1e37f1b8d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","rdfs:label":"Patient VII-3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":31,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/4f78b33a-6f72-4bb0-813a-6a7376086415"},{"id":"https://genegraph.clinicalgenome.org/r/f34451f8-1c6e-4567-ad23-2feab877a79f"}],"detectionMethod":"exons, intron-exon boundaries and untranslated regions of AGXT screened via PCR and direct sequencing; both patients and family members underwent testing","phenotypes":"obo:HP_0000787","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/51c6fdfd-4229-4a66-8efd-195dbf3eae86_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/6cb8c15a-7140-4341-be04-7078fdbbcd3c_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/650401ef-1fd3-4f56-8bd6-84acf505b517_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f4dce4c1-1f1c-4488-a2c4-a29df34619d0","type":"EvidenceLine","dc:description":"variant on minor allele and absent from gnomAD","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f4dce4c1-1f1c-4488-a2c4-a29df34619d0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27915025","allele":{"id":"https://genegraph.clinicalgenome.org/r/f4b58d0b-6f21-47b4-816e-b8cc1a565646","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.733_734del (p.Lys245ValfsTer9)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915940274"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/650401ef-1fd3-4f56-8bd6-84acf505b517","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27915025","rdfs:label":"Patient 9-Family G","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":18,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f4b58d0b-6f21-47b4-816e-b8cc1a565646"},"detectionMethod":"Sequence analyses of AGXT gene were performed by using 25 ng PCR product, 3 pmol primer and BigDye Terminator","phenotypeFreeText":"bilateral nephrocalcinosis; treated with supportive therapy for kidney disease (peritoneal dialysis) and pyridoxine","phenotypes":["obo:HP_0003774","obo:HP_0000121","obo:HP_0000787","obo:HP_0002027","obo:HP_0003159"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f4dce4c1-1f1c-4488-a2c4-a29df34619d0_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/002c9455-64af-4ad1-b4fd-f89e491788e4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a8f64b5d-8e56-41ec-b071-a0c4e167e4a1","type":"EvidenceLine","dc:description":"variant present on major allele; gnomAD frequency = 0.00001194; variant reported in one other proband in paper","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a8f64b5d-8e56-41ec-b071-a0c4e167e4a1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27915025","allele":{"id":"https://genegraph.clinicalgenome.org/r/10f41123-b9cc-4217-a7f4-24d9a069974c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.817_818AG[5] (p.Ser275fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/204201"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/002c9455-64af-4ad1-b4fd-f89e491788e4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27915025","rdfs:label":"Patient 10-Family H","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":8,"allele":{"id":"https://genegraph.clinicalgenome.org/r/10f41123-b9cc-4217-a7f4-24d9a069974c"},"detectionMethod":"Sequence analyses of AGXT gene were performed by using 25 ng PCR product, 3 pmol primer and BigDye Terminator","phenotypeFreeText":"bilateral nephrolithiasis and nephrocalcinosis, treated with pyridoxine","phenotypes":["obo:HP_0003159","obo:HP_0012624","obo:HP_0000121","obo:HP_0000787","obo:HP_0000010"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/a8f64b5d-8e56-41ec-b071-a0c4e167e4a1_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ea94a0ae-602a-40a0-81cc-8c58d9a85139_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/69cb7070-b638-4216-a847-06c330b78c3d","type":"EvidenceLine","dc:description":"Scored as zero due to no evidence of variants being in trans. p.Arg122Ter: stated to be heterozygous, gnomAD = 0.000006284,","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/69cb7070-b638-4216-a847-06c330b78c3d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot showed variant resulted in 100% loss of AGT protein expression (Fig. 2) and mass spec showed 100% loss of protein activity","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/69cb7070-b638-4216-a847-06c330b78c3d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","allele":{"id":"https://genegraph.clinicalgenome.org/r/710c0582-7d5a-409c-b534-5af7fda26cdd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.364C>T (p.Arg122Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/204097"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f7550ecd-dbef-4e9c-957a-a736728de8c7","type":"EvidenceLine","dc:description":"Scored as zero due to no evidence of variants being in trans. p.Arg36His: stated to be heterozygous, gnomAD = 0.00001210","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7550ecd-dbef-4e9c-957a-a736728de8c7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mass spec showed variant resulted in partial loss of protein activity","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/f7550ecd-dbef-4e9c-957a-a736728de8c7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","allele":{"id":"https://genegraph.clinicalgenome.org/r/3c14b06e-0531-4556-9026-c27b72f57f20","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.107G>A (p.Arg36His)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/204072"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ea94a0ae-602a-40a0-81cc-8c58d9a85139","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","rdfs:label":"Patient II-3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":22,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/3c14b06e-0531-4556-9026-c27b72f57f20"},{"id":"https://genegraph.clinicalgenome.org/r/710c0582-7d5a-409c-b534-5af7fda26cdd"}],"detectionMethod":"exons, intron-exon boundaries and untranslated regions of AGXT screened via PCR and direct sequencing; both patients and family members underwent testing","phenotypeFreeText":"serum creatine = 125 umol/L","phenotypes":"obo:HP_0000787","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/f7550ecd-dbef-4e9c-957a-a736728de8c7_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/69cb7070-b638-4216-a847-06c330b78c3d_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/51169a04-5b8b-4977-8906-3f2bc6958006_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c4ebd5ff-1b6e-4d7f-ac24-ebc305966b5b","type":"EvidenceLine","dc:description":"Variant present in one other related individual (nephew), and 2 other unrelated individuals with similar phenotypes; not stated whether variant is present on major vs. minor allele; gnomAD frequency = 0.00001990. Score increased for multiple occurrences.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c4ebd5ff-1b6e-4d7f-ac24-ebc305966b5b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 17696873 - Biochemical and spectroscopic studies have shown this variant does not disrupt binding with PLP and pyridoxamine monophosphate, but shows reduced binding affinity resulting in decreased Kcat while maintaining Km","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c4ebd5ff-1b6e-4d7f-ac24-ebc305966b5b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1349575","allele":{"id":"https://genegraph.clinicalgenome.org/r/d2f8c610-784b-426c-83d3-aaf0badbc3a8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.245G>A (p.Gly82Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/5643"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/51169a04-5b8b-4977-8906-3f2bc6958006","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1349575","rdfs:label":"Patient 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":27,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d2f8c610-784b-426c-83d3-aaf0badbc3a8"},"detectionMethod":"first strand cDNA synthesized from total liver RNA from patient to be used as template for PCR of the coding region of AGXT cDNA, PCR product cloned into pBluescript and was sequenced and compared to normal AGT, exon 2 of AGXT was amplified via PCR and sequenced from 14 clones from 2 amplifications to confirm variant (Fig. 2b)","phenotypeFreeText":"AGT enzymatic activity <2% of mean normal level, normal amount of immunoreactive AGT protein, Northern blot showed presence of normal molecular weight and abundance of AGXT mRNA","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c4ebd5ff-1b6e-4d7f-ac24-ebc305966b5b_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/faf86703-1d44-48e8-96f5-baa23596c308_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/25612552-a26c-4fbc-a0e8-43e47e2585ab","type":"EvidenceLine","dc:description":"variant present on major allele and absent from gnomAD","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/25612552-a26c-4fbc-a0e8-43e47e2585ab_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27915025","allele":{"id":"https://genegraph.clinicalgenome.org/r/9432e91c-7089-41f0-9f56-6d21e9001a0f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.166-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/204163"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/faf86703-1d44-48e8-96f5-baa23596c308","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27915025","rdfs:label":"Patient 12-Family J","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":12,"allele":{"id":"https://genegraph.clinicalgenome.org/r/9432e91c-7089-41f0-9f56-6d21e9001a0f"},"detectionMethod":"Sequence analyses of AGXT gene were performed by using 25 ng PCR product, 3 pmol primer and BigDye Terminator","phenotypeFreeText":"treated with supportive therapy for kidney disease (peritoneal dialysis) and pyridoxine, bilateral nephrolithiasis and nephrocalcinosis","phenotypes":["obo:HP_0003159","obo:HP_0000787","obo:HP_0012587","obo:HP_0000121","obo:HP_0003774"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/25612552-a26c-4fbc-a0e8-43e47e2585ab_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a1baf0df-07a6-4a4f-af74-7f29b78193ed_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d2dcfdcf-a11f-4030-8b26-cf9ae2f4af29","type":"EvidenceLine","dc:description":"Variant cosegregates with major allele and results in a premature stop codon (p.Gln137Hisfs*19), parents confirmed heterozygous, variant absent from gnomAD","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d2dcfdcf-a11f-4030-8b26-cf9ae2f4af29_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27659337","allele":{"id":"https://genegraph.clinicalgenome.org/r/df282842-8081-4f84-97ee-c5f6e959d168","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.406_410dup (p.Gln137HisfsTer19)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/557281"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a1baf0df-07a6-4a4f-af74-7f29b78193ed","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27659337","rdfs:label":"Patient II-5","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"allele":{"id":"https://genegraph.clinicalgenome.org/r/df282842-8081-4f84-97ee-c5f6e959d168"},"detectionMethod":"genomic DNA extracted from peripheral blood leukocytes, 7 most frequent variants ((c.33dupC(p.Lys12GlnfsX156), c.508G>A (p.G170R), c.731T>C(p.I244T), c.454T>A (p.F152I), c.322T>C (p.W108R),c.976delG (p.Val326fs) and c.588G>A (p.G156R)) tested by PCR and restriction digestion; then 11 exons and exon-intron boundaries amplified via PCR the directly sequenced","phenotypeFreeText":"treated with dialysis therapy for 7years prior to study, urolithiasis, 24h urinary oxalate excretion = 1828mmol/L, oxalate:creatine ratio = 0.712mmol/mmol, hyperglycoluria (>0.5 mmol/1.73 m2per 24 h), positive crystalluria with calcium oxalate monohydrate stones and some crystals >200/mm^3, clearance = 70mL/min per 1.73m^2, urea=7mmol/L, creatinine=60Î¼mol/L, Na=135 mmol/L, K=4.2 mmol/L, Ca=2.6 mmol/L, Hb=10 g/dL, positive cytobacteriological urine exam for Proteus germ, quick progression to end stage renal disease, treated with hemodialysis and pyridoxine therapy, after 2 years had multiorgan failure due to systemic oxalosis","phenotypes":["obo:HP_0000787","obo:HP_0000980","obo:HP_0000822","obo:HP_0001919","obo:HP_0000969","obo:HP_0000010","obo:HP_0003774","obo:HP_0003159","obo:HP_0000121"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d2dcfdcf-a11f-4030-8b26-cf9ae2f4af29_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9614098c-a6a9-4099-985e-14bcef038379_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f192581-7f11-420f-a2b6-9d14619ebddc","type":"EvidenceLine","dc:description":"Proband is homozygous for the Ser205Pro change. gnomAD frequency = 0.000007079","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f192581-7f11-420f-a2b6-9d14619ebddc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"AGXT shown to have reduced expression and reduced enzymatic activity by Western blot and immunocytochemical analysis of patient's liver","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2f192581-7f11-420f-a2b6-9d14619ebddc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/2039493","allele":{"id":"https://genegraph.clinicalgenome.org/r/aa3fbdd9-8c17-47b7-8c4a-2f2f5b6bf35a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.613T>C (p.Ser205Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/5640"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/9614098c-a6a9-4099-985e-14bcef038379","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/2039493","rdfs:label":"PHT patient","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":46,"allele":{"id":"https://genegraph.clinicalgenome.org/r/aa3fbdd9-8c17-47b7-8c4a-2f2f5b6bf35a"},"detectionMethod":"cDNA library constructed from patient's liver, isolated AGXT cDNA, sequence analysis of isolated clones, Southern blot analysis of patient and control DNA to detect variant (Fig. 2)","phenotypeFreeText":"absence of alanine:glycoxylate aminotransferase, recurrent urinary calculi from 6yo, required hemodialysis for end-stage renal failure at 39yo, high plasma oxalate concentration, cytoplasmic extracts from liver autopsy showed AGXT enzymatic activity to be one-hundredth of controls","phenotypes":["obo:HP_0003774","obo:HP_0003159"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2f192581-7f11-420f-a2b6-9d14619ebddc_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/25acfaf6-f7c5-4cad-b85d-3d7d0733e207_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/79430332-f86f-4f27-8a90-051730c5f99a","type":"EvidenceLine","dc:description":"variant on major allele and absent from gnomAD; variant present in 3 other probands reported in this paper","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/79430332-f86f-4f27-8a90-051730c5f99a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27915025","allele":{"id":"https://genegraph.clinicalgenome.org/r/33dd0248-6dec-4501-9c67-c3ed0b82d2a3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.969_970TG[1] (p.Val324fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/204209"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/25acfaf6-f7c5-4cad-b85d-3d7d0733e207","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27915025","rdfs:label":"Patient 4-Family C","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/33dd0248-6dec-4501-9c67-c3ed0b82d2a3"},"detectionMethod":"Sequence analyses of AGXT gene were performed by using 25 ng PCR product, 3 pmol primer and BigDye Terminator","phenotypeFreeText":"supportive therapy for kidney failure and pyridoxine, bilateral nephrolithiasis and nephrocalcinosis","phenotypes":["obo:HP_0000787","obo:HP_0000121","obo:HP_0003159","obo:HP_0003774","obo:HP_0001508"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/79430332-f86f-4f27-8a90-051730c5f99a_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e2abd781-cab3-47b0-93fe-00d363f1a2b9_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11967a39-7e35-41dd-bee9-4a8a9ab31c7d","type":"EvidenceLine","dc:description":"Scored as zero due to no evidence of variants being in trans.p.Leu33Met: stated to be heterozygous, absent from gnomAD","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11967a39-7e35-41dd-bee9-4a8a9ab31c7d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot showed variant resulted in 30.7% expression of AGXT protein compared to WT (Fig. 2) and mass spec showed variant resulted in partial loss of protein activity (Fig. 3)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/11967a39-7e35-41dd-bee9-4a8a9ab31c7d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","allele":{"id":"https://genegraph.clinicalgenome.org/r/c6908f40-25a2-4482-9b4d-5ffe14fccdee","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.97C>A (p.Leu33Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351313091"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/dfd52289-7754-40e7-8644-ef8f06806100","type":"EvidenceLine","dc:description":"Scored as zero due to no evidence of variants being in trans p.Gly350Asp: stated to be homozygous, gnomAD = 0.00004393","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dfd52289-7754-40e7-8644-ef8f06806100_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mass spec showed variant resulted in partial loss of protein activity (Fig. 3) ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/dfd52289-7754-40e7-8644-ef8f06806100_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","allele":{"id":"https://genegraph.clinicalgenome.org/r/d5592131-5bd8-49b5-9ce6-e0858b148a8c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.1049G>A (p.Gly350Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/188986"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e2abd781-cab3-47b0-93fe-00d363f1a2b9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","rdfs:label":"Patient I-21","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":18,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/c6908f40-25a2-4482-9b4d-5ffe14fccdee"},{"id":"https://genegraph.clinicalgenome.org/r/d5592131-5bd8-49b5-9ce6-e0858b148a8c"}],"detectionMethod":"exons, intron-exon boundaries and untranslated regions of AGXT screened via PCR and direct sequencing; both patients and family members underwent testing","phenotypeFreeText":"serum creatine = 730 umol/L","phenotypes":"obo:HP_0000787","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/dfd52289-7754-40e7-8644-ef8f06806100_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/11967a39-7e35-41dd-bee9-4a8a9ab31c7d_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/07c4b1c0-fc97-48c1-8b29-0d315953a546_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b47b7689-64eb-4652-a802-cc9db2ad1c1d","type":"EvidenceLine","dc:description":"Parents confirmed to be heterozygous, not stated if on major vs. minor alllele, gnomAD frequency = 0.00003203","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b47b7689-64eb-4652-a802-cc9db2ad1c1d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18810341","allele":{"id":"https://genegraph.clinicalgenome.org/r/4743300f-b8b4-4de0-9fda-81351ce59ca6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.302T>C (p.Leu101Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/188866"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/07c4b1c0-fc97-48c1-8b29-0d315953a546","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18810341","rdfs:label":"Case 2","ageType":"AgeAtReport","ageUnit":"Months","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/4743300f-b8b4-4de0-9fda-81351ce59ca6"},"detectionMethod":"genomic DNA extracted from peripheral blood, entire AGXT coding sequence PCR amplified, Sanger sequencing; both parents and unaffected sibling also tested","phenotypeFreeText":"at exam: weight = 5Kg, head circumference = 38.6cm, length = 60cm. Hemoglobin level of 11 g/dl; blood level of urea was 16mg/dl, creatinine 0.5 mg/dl, sodium 148 mEq/l, potassium 4.8 mEq/l, calcium 9.3 mg/dl, phosphate 4.3mg/dl, alkaline phosphatase 676 IU/l, pH 7.47 andbicarbonate 19.8 mEq/l, 24-hrurinary oxalate was 242 mg/1.73 m2 per 24-hr, on treatment with oral pyridoxine","phenotypes":["obo:HP_0000282","obo:HP_0003159","obo:HP_0012408"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b47b7689-64eb-4652-a802-cc9db2ad1c1d_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2498aa02-2c3d-4cc2-8d4a-b16cff054de8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c5726775-efd5-400e-a935-59c9b98a1afd","type":"EvidenceLine","dc:description":"Both parents tested: Mother heterozygous for p.Gly216Arg (gnomAD frequency = 0.000003982), c.33dup (absent in gnomAD) absent in father (paternity confirmed via microsatellite) therefore variant was asserted to be de novo on the paternal allele in the proband","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c5726775-efd5-400e-a935-59c9b98a1afd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16931222","allele":{"id":"https://genegraph.clinicalgenome.org/r/f34451f8-1c6e-4567-ad23-2feab877a79f"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8c3037c0-fcf2-433e-aa31-c30eb65aeff8","type":"EvidenceLine","dc:description":"Both parents tested: Mother heterozygous for p.Gly216Arg (gnomAD frequency = 0.000003982), c.33dup (absent in gnomAD) absent in father (paternity confirmed via microsatellite) therefore variant was asserted to be de novo on the paternal allele in the proband","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c3037c0-fcf2-433e-aa31-c30eb65aeff8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16931222","allele":{"id":"https://genegraph.clinicalgenome.org/r/b10adcb6-e477-422b-83d9-ea4c34140a1a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.646G>A (p.Gly216Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/204121"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/2498aa02-2c3d-4cc2-8d4a-b16cff054de8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16931222","rdfs:label":"II-1","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/f34451f8-1c6e-4567-ad23-2feab877a79f"},{"id":"https://genegraph.clinicalgenome.org/r/b10adcb6-e477-422b-83d9-ea4c34140a1a"}],"detectionMethod":"Linkage analysis and full gene sequencing","phenotypeFreeText":"left-sided urolithiasis, stone analysis showed calcium oxalate monohydrate, normal height and weight, blood pressure = 110/60 mm/Hg, abdomen soft and tender with no flank pain, normal fundoscopy, serum creatinine level = 0.6mg/dL, urinalysis showed pH of 6.5, urinary calcium excretion = 0.02 mmol/kg/d, oxalate excretion = 248 mg/1.73 m2/d, elevated urinary glycolate excretion = 186 \u0001g/mg creatinine, plasma oxalate level elevated at 11 \u0001mol/L. At 16yo patient is: obese (BMI = 29.4 kg/m2) with serum creatinine level of 1.0 mg/dL, and glomerular filtration rate of 98 mL/min/1.73 m2","phenotypes":["obo:HP_0011848","obo:HP_0002907","obo:HP_0003159","obo:HP_0001513"],"previousTesting":true,"previousTestingDescription":"negative for the common c.508A and c.731C AGXT variants","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/c5726775-efd5-400e-a935-59c9b98a1afd_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/8c3037c0-fcf2-433e-aa31-c30eb65aeff8_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.1},{"id":"https://genegraph.clinicalgenome.org/r/1a44a0fb-92b1-4f5a-9c1c-a063de5b52f3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/242127f8-cc92-4b4f-9f50-ff2c86806c29","type":"EvidenceLine","dc:description":"Scored as zero due to no evidence of variants being in trans patient also reported to have variant NM_000030.3(AGXT):c.1020A>G (p.Ile340Met) in the homozygous state, ClinVar:39486, gnomAD = 0.1637.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/242127f8-cc92-4b4f-9f50-ff2c86806c29_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mass spec showed variant resulted in partial loss of protein activity (Fig. 3)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/242127f8-cc92-4b4f-9f50-ff2c86806c29_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","allele":{"id":"https://genegraph.clinicalgenome.org/r/5d75b390-764a-452f-97c0-a2ed77a7d901","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.590G>A (p.Arg197Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/92312"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c1aa8343-69b5-4bf9-b3be-f34612cfde40","type":"EvidenceLine","dc:description":"Scored as zero due to no evidence of variants being in trans. patient also reported to have variant NM_000030.3(AGXT):c.1020A>G (p.Ile340Met) in the homozygous state, ClinVar:39486, gnomAD = 0.1637, Western blot showed variant resulted in 15.7% expression of AGXT protein compared to WT (Fig. 2) and mass spec showed variant resulted in partial loss of protein activity (Fig. 3)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c1aa8343-69b5-4bf9-b3be-f34612cfde40_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot showed variant resulted in 100% loss of AGT protein expression (Fig. 2) and mass spec showed 100% loss of protein activity","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c1aa8343-69b5-4bf9-b3be-f34612cfde40_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","allele":{"id":"https://genegraph.clinicalgenome.org/r/1a9bfee8-7f56-4d51-9e53-83bdf3e8689c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.557C>T (p.Ala186Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/92311"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/1a44a0fb-92b1-4f5a-9c1c-a063de5b52f3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","rdfs:label":"Patient IV-3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":43,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/1a9bfee8-7f56-4d51-9e53-83bdf3e8689c"},{"id":"https://genegraph.clinicalgenome.org/r/5d75b390-764a-452f-97c0-a2ed77a7d901"}],"detectionMethod":"exons, intron-exon boundaries and untranslated regions of AGXT screened via PCR and direct sequencing; both patients and family members underwent testing","phenotypeFreeText":"serum creatine = 515 umol/L","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/c1aa8343-69b5-4bf9-b3be-f34612cfde40_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/242127f8-cc92-4b4f-9f50-ff2c86806c29_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/3603ebf3-ad0d-4244-a9d3-1171f021d68a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5e442837-df19-4160-9d4b-77250fcecb16","type":"EvidenceLine","dc:description":"Scored as zero due to no evidence of variants being in trans p.Gly41Trp: stated to be heterozygous, absent from gnomAD","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5e442837-df19-4160-9d4b-77250fcecb16_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mass spec showed variant resulted in partial loss of protein activity (Fig. 3) ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/5e442837-df19-4160-9d4b-77250fcecb16_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","allele":{"id":"https://genegraph.clinicalgenome.org/r/c266bed0-d94d-4842-b14f-149b7c43f24e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.121G>T (p.Gly41Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351313173"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d45aeb97-f78d-4e54-aa85-fb8ef28d5713","type":"EvidenceLine","dc:description":"Scored as zero due to no evidence of variants being in trans. p.Arg111Ter: stated to be heterozygous, absent from gnomAD","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d45aeb97-f78d-4e54-aa85-fb8ef28d5713_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot showed variant resulted in 100% loss of AGT protein expression (Fig. 2) and mass spec showed 100% loss of protein activity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d45aeb97-f78d-4e54-aa85-fb8ef28d5713_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","allele":{"id":"https://genegraph.clinicalgenome.org/r/3f5a70b7-7166-49b5-9d97-945c76527c6f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/3603ebf3-ad0d-4244-a9d3-1171f021d68a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30341509","rdfs:label":"Patient III-3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":22,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/3f5a70b7-7166-49b5-9d97-945c76527c6f"},{"id":"https://genegraph.clinicalgenome.org/r/c266bed0-d94d-4842-b14f-149b7c43f24e"}],"detectionMethod":"exons, intron-exon boundaries and untranslated regions of AGXT screened via PCR and direct sequencing; both patients and family members underwent testing","phenotypeFreeText":"serum creatine = 1103 umol/L","phenotypes":"obo:HP_0000787","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d45aeb97-f78d-4e54-aa85-fb8ef28d5713_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5e442837-df19-4160-9d4b-77250fcecb16_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/8460f17d-4d94-4a0c-ac46-41c86ce32e83_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5bd4f3bb-0db6-49f4-9a7a-1a2b66355e97_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16931222","rdfs:label":"PH1 Family","estimatedLodScore":0.5,"family":{"id":"https://genegraph.clinicalgenome.org/r/5bd4f3bb-0db6-49f4-9a7a-1a2b66355e97","type":"Family","rdfs:label":"PH1 Family","member":{"id":"https://genegraph.clinicalgenome.org/r/2498aa02-2c3d-4cc2-8d4a-b16cff054de8"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/2498aa02-2c3d-4cc2-8d4a-b16cff054de8"}},{"id":"https://genegraph.clinicalgenome.org/r/a9302797-6347-4673-bbbc-602a7befa41e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27659337","rdfs:label":"Family 1","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/a9302797-6347-4673-bbbc-602a7befa41e","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/a1baf0df-07a6-4a4f-af74-7f29b78193ed"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/a1baf0df-07a6-4a4f-af74-7f29b78193ed"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7d437d19-13b0-4c31-95ad-87d0ebeb9f26_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c36ca582-d48c-40e8-bac6-7f60fa1d6ea8","type":"EvidenceLine","dc:description":"Parents confirmed heterozygous (parent 1a carrying c.121G>A and parent 1b carrying c.576T>A), both patient and parents were also homozygous for c.32C>T (p.Pro11Leu) p.Gly41Arg on major allele, gnomAD frequency = 0.00001213.p.Phe152Ile on minor allele, gnomAD frequency = 0.00008271","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c36ca582-d48c-40e8-bac6-7f60fa1d6ea8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant predicted to be responsible for interperoxisomal aggregation of AGXT protein either by itself or in conjunction with p.Pro11Leu (PMID: 8101040), Also shown to have 7% residual activity when expressed alone on the background of the major AGT allele (PMID: 10960483)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c36ca582-d48c-40e8-bac6-7f60fa1d6ea8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8101040","allele":{"id":"https://genegraph.clinicalgenome.org/r/2fcb6954-dd70-45b8-a3fe-d2e3a17168f1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.454T>A (p.Phe152Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/5645"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/dd9d170c-afed-4e38-a629-e444f810954b","type":"EvidenceLine","dc:description":"Parents confirmed heterozygous (parent 1a carrying c.121G>A and parent 1b carrying c.576T>A), both patient and parents were also homozygous for c.32C>T (p.Pro11Leu) p.Gly41Arg on major allele, gnomAD frequency = 0.00001213","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd9d170c-afed-4e38-a629-e444f810954b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant predicted to be responsible for interperoxisomal aggregation of AGXT protein either by itself or in conjunction with p.Pro11Leu (PMID: 8101040), Also shown to have 7% residual activity when expressed alone on the background of the major AGT allele (PMID: 10960483)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/dd9d170c-afed-4e38-a629-e444f810954b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8101040","allele":{"id":"https://genegraph.clinicalgenome.org/r/72b675e6-6966-4ee2-a3f2-7da088bf8610","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000030.3(AGXT):c.121G>A (p.Gly41Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/5644"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7d437d19-13b0-4c31-95ad-87d0ebeb9f26","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8101040","rdfs:label":"Patient 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":21,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/72b675e6-6966-4ee2-a3f2-7da088bf8610"},{"id":"https://genegraph.clinicalgenome.org/r/2fcb6954-dd70-45b8-a3fe-d2e3a17168f1"}],"detectionMethod":"reverse transcription PCR, Sspl-PvuII cDNA fragment (containing AGXT coding region) was cloned and sequenced, parental testing by exon-specific PCR and restriction digestion analysis","firstTestingMethod":"PCR","phenotypeFreeText":"end-stage renal failure at 16yo requiring hemodialysis treatment and living related kidney transplant, but after 2 years required both liver and kidney transplant, PHI confirmed via enzymatic analysis of liver biopsy\n\nLiver biopsy: AGT = 0.38, GGT = 0.85, intermediate amount of AGT immunoreactive protein, AGT activity is 0% of normal (AGT values in parents comparable to that expected of heterozygotes)\n\nA-gold immunoeclectrion microscopy showed bicompartmental distribution of AGT protein with reduce levels distributed equally between peroxisomes and mitochondria (Fig. 2), peroxisomes had amorphous core-like structures which harbored most of the AGT immunoreactivity rather than the matrix (table 2)","phenotypes":["obo:HP_0000121","obo:HP_0003774"],"secondTestingMethod":"Restriction digest","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/dd9d170c-afed-4e38-a629-e444f810954b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/c36ca582-d48c-40e8-bac6-7f60fa1d6ea8_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":4285,"specifiedBy":"GeneValidityCriteria7","strengthScore":16.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/wcXXsP77ZPo","type":"GeneValidityProposition","disease":"obo:MONDO_0100278","gene":"hgnc:341","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_8460f17d-4d94-4a0c-ac46-41c86ce32e83-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}